Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

869.50p

Change Today:

-18.50p
52 Week High: 1,445.00
52 Week Low: 576.50

Currency: UK Pounds
Shares Issued: 40.29m
Volume: 131,333

Market Cap: £350.35m
RiskGrade: 314

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

1 Day Chart

6 Month Chart

More Indivior charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-1.9%	23.2%
ROCE	n/a

	Latest	F'cast
P/E	n/a	7.0
PEG	n/a	n/a
Pr/Revenue	0.4	0.8
Pr/Book	n/a

	Latest	F'cast
Revenue	8.7%	-33.5%
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

Indivior Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	647.00	(173.00)	40.00¢	18.2	n/a	-67%	n/a	0.0%
31-Dec-21	791.00	190.00	19.20¢	89.4	n/a	-52%	n/a	0.0%
31-Dec-22	901.00	(95.00)	(38.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	1,093.00	1.00	1.00¢	1,583.7	n/a	n/a	n/a	0.0%
31-Dec-24	1,188.00	(43.00)	(36.00)¢	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Indivior Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-25	1,056.02	245.17	97.98p	9.1	n/a	n/a	n/a	0.0%
31-Dec-26	1,087.93	259.32	109.39p	8.1	0.7	+12%	n/a	0.0%
31-Dec-27	1,146.12	294.02	126.61p	7.0	0.4	+16%	n/a	0.0%

Indivior forecasts

Indivior Company Announcements

Director/PDMR Shareholding	06-May-2025	13:48	RNS
Total Voting Rights	01-May-2025	09:21	RNS
1st Quarter Results	24-Apr-2025	07:00	RNS

More indivior company announcements

Indivior ShareCast News

Indivior shrinks board following pressure from a...	04-Mar-2025	ShareCast
London close: Stocks mixed on corporate earnings...	27-Feb-2025	ShareCast
Pharma veteran Ciaffoni to take CEO reins at Ind...	27-Feb-2025	ShareCast

More Indivior ShareCast news

Latest Indivior Director Deals

Traded	Action	Notifier	Price	Amount	Value
05-May-25	Buy	Mark Stejbach	902.62p	1,000	£9,026.22
17-Mar-25	Transfer From	Mark Crossley	0.000p	9,974	£0.00
10-Mar-25	Transfer From	Mark Crossley	0.000p	243,282	£0.00

More Indivior director deals

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

Indivior Market Data

Currency	UK Pounds
Share Price	869.50p
Change Today	-18.50p
% Change	-2.08 %
52 Week High	1,445.00
52 Week Low	576.50
Volume	131,333
Shares Issued	40.29m
Market Cap	£350.35m
RiskGrade	314